Clinical Trial Update: Efficacy Study of PDE-5 Inhibitor and Calcium Channel Inhibitor for the Treatment of Secondary Raynaud Phenomenon [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial update reports results from Phase 2 and Phase 3 studies evaluating a PDE-5 inhibitor in combination with a calcium channel inhibitor for the trea…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Raynaud Phenomenon

Snippet

Sponsor: Seoul National University Hospital | Conditions: Raynaud Phenomenon | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2012-12-11